JMS News

JMS: Announcements of individual stocks regarding disposal of treasury stock as share-based compensation with transfer restrictions.

Jul 17 02:00 ET

JMS: Corporate Governance Report June 26, 2024

Jun 26 02:26 ET

JMS: Interim report

Jun 25 22:22 ET

JMS: Internal Control Report - 59th Term (2023/04/01 - 2024/03/31)

Jun 25 22:10 ET

JMS: Confirmation letter

Jun 25 22:05 ET

JMS: Financial Report - 59th Term (2023/04/01 - 2024/03/31)

Jun 25 21:55 ET

JMS: Announcements of individual stocks regarding the exclusive sales and cooperation agreement with Terumo Shanghai.

Jun 4 22:00 ET

JMS: Notification of the regular shareholders' meeting in 2024.

Jun 3 19:00 ET

JMS: Notice of Regular Shareholders' Meeting Convened in 2024 and Shareholders' Meeting Materials.

Jun 3 19:00 ET

JMS: Teijin Pharma and JMS signed an agreement to establish a joint venture focusing on peritoneal dialysis

May 19 22:00 ET

JMS: Notice regarding the formulation of a medium-term management plan

May 14 02:00 ET

JMS: 2024 financial results overview

May 14 02:00 ET

JMS: Notice regarding the change of representative director

May 14 02:00 ET

JMS: Notice regarding differences between full-year consolidated earnings forecasts and actual results

May 14 02:00 ET

JMS: Summary of Financial Results for the Fiscal Year Ending March 31, 2024 [Japanese GAAP] (Consolidated)

May 14 02:00 ET

JMS: Notice regarding personnel changes

Mar 26 02:00 ET

JMS: Confirmation

Feb 12 20:51 ET

JMS: Quarterly Report - 59th Quarter 3 (2023/10/01 to 2023/12/31)

Feb 12 20:46 ET

JMS: Summary of Financial Results for the third quarter 2024

Feb 8 01:00 ET

JMS: Summary of Financial Results for the 3rd Quarter of the Fiscal Year Ending March 31, 2024 [Japanese GAAP] (Consolidated)

Feb 8 01:00 ET